Collaboration - May 21, 2025
NextCell enters collaboration with Fujifilm Irvine Scientific
The two companies will bring together their core competences in mesenchymal stromal cells (MSCs) and raw materials for the life science sector.
Collaboration - May 15, 2025
Novo Nordisk and Septerna to collaborate
The two companies have announced an exclusive global collaboration and license agreement to discover, develop and commercialize oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.
Pharma Business - May 12, 2025
Aqilion receives IND approval
The US Food and Drug Administration (FDA) has approved Aqilion's IND (investigational new drug) application for the drug candidate AQ280.
Financing - May 7, 2025
RECCAN secures SEK 7 million
The company has raised financing through a private placement led by Sandberg Development.
Pharma Business - May 5, 2025
Cantargia announces second target indication for CAN10
Cantargia has announced the selection of a subgroup of atopic dermatitis (AD) patients, not responding to first line dupilumab treatment, as its second target indication for CAN10.
Pharma Business - April 29, 2025
Purpose Pharma receives positive CHMP opinion
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Attrogy (diflunisal) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.
